News

Filter

Current filters:

Dexfenfluramine

1 to 9 of 128 results

Locaserin trial passes 1-year safety review

31-03-2008

The USA's Arena Pharmaceuticals is continuing a pivotal Phase III trial of its obesity drug locaserin…

DexfenfluramineReduxWyeth

Wyeth says 7th Amendment to diet drug settlement gets final judicial review

05-06-2006

After years of litigation, US health care giant Wyeth says that the Seventh Amendment to the Nationwide…

DexfenfluramineReduxWyeth

Servier pays up over Redux/Ponderal in Canada

06-06-2005

French independant pharmaceutical producer Laboratoires Servier has accepted that it must pay C$13.3…

DexfenfluramineReduxServier

Manhattan's obesity drug: strong results

06-06-2005

New York, USA-based Manhattan Pharmaceuticals says that its lead candidate drug, the anti-obesity agent…

DexfenfluramineFastinPhentermineRedux

Servier will pay to avoid legal action

27-09-2004

French drugmaker Laboratoires Servier is to pay out about $40 million in an agreement described as amicable…

DexfenfluramineReduxServier

Wyeth wins multiple Philadelpha diet drug cases

23-08-2004

Wyeth has announced that the jury deliberating over four combinedfen-phen diet drug cases in the Court…

DexfenfluramineFenfluramine - Removed from US MarketPondiminReduxWyeth

Antiobesity drugs still performing under par in the USA, despite its 60M sufferers

08-03-2004

Obesity is a chronic disease affecting approximately 60 million of the adult population in the USA alone.…

DexfenfluramineFastinFenfluramine - Removed from US MarketorlistatPhenterminePondiminReduxRocheXenical

European court overturns obesity drug ban

03-02-2003

The European Court of First Instance has overturned a ban imposed by theEuropean Commission on the notorious…

DexfenfluramineFastinFenfluramine - Removed from US MarketPhenterminePondiminReduxServierWyeth

1 to 9 of 128 results

COMPANY SPOTLIGHT

Menarini

Back to top